Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
max-40279-01 (4 trials)
regorafenib (stivarga) (1 trial)
max-10181 (1 trial)
max-40279 (1 trial)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Neoplasms (Phase 1)
Trials (6 total)
Trial APIs (4 total)